SynthesisFrontiers in immunology2024

Clinical benefit analysis of PD-1 inhibitors in patients with advanced, recurrent or metastatic cervical cancer: a meta-analysis and systematic review.

Yun-Zi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.